151. The risk of cutaneous mucormycosis associated with COVID-19: A perspective from Pakistan.
- Author
-
Asri S, Akram MR, Hasan MM, Asad Khan FM, Hashmi N, Wajid F, and Ullah I
- Subjects
- Humans, Pakistan epidemiology, Pandemics, SARS-CoV-2, COVID-19 complications, Mucormycosis complications, Mucormycosis epidemiology, Mucormycosis microbiology
- Abstract
As a developing country, Pakistan reports a high burden of fungal diseases, of which cutaneous mucormycosis remains a prominent infection, presenting as a highly invasive disease with significant mortality. Apart from a high population of at-risk individuals, multiple factors have precipitated an increment in mucormycosis cases in the country following the COVID-19 pandemic. These include increased use of corticosteroids, immunosuppression following the viral infection, prolonged stays in the intensive care unit and sub-optimal laboratory testing available in the country. This article aims to assess the potential implications of a mucormycosis epidemic on a healthcare system already strained under the COVID-19 pandemic, and provides subsequent recommendations to weather the dual challenge of two deadly pathogens., (© 2021 John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF